精(jing)華(hua)制藥(yao)(yao)(yao)集團股份有(you)限(xian)公(gong)司是由南(nan)通(tong)(tong)(tong)(tong)產控集團控股、國(guo)資(zi)監管的地方國(guo)有(you)控股企業,由原南(nan)通(tong)(tong)(tong)(tong)中誠制藥(yao)(yao)(yao)有(you)限(xian)公(gong)司(南(nan)通(tong)(tong)(tong)(tong)中藥(yao)(yao)(yao)廠(chang)(chang))變更、重(zhong)組南(nan)通(tong)(tong)(tong)(tong)制藥(yao)(yao)(yao)總廠(chang)(chang)(南(nan)通(tong)(tong)(tong)(tong)制藥(yao)(yao)(yao)廠(chang)(chang)、南(nan)通(tong)(tong)(tong)(tong)制藥(yao)(yao)(yao)二(er)廠(chang)(chang))優質資(zi)源,并吸收民營資(zi)本南(nan)通(tong)(tong)(tong)(tong)綜(zong)藝投資(zi)有(you)限(xian)公(gong)司以及自(zi)然(ran)人投資(zi)設立(li)。2010年2月(yue)在(zai)深交所中小板掛牌上市(shi),股票簡稱:精(jing)華(hua)制藥(yao)(yao)(yao),證券代號:002349。
公(gong)(gong)(gong)司(si)已有(you)(you)60多年(nian)的(de)制(zhi)(zhi)(zhi)藥(yao)(yao)歷史,是一家綜(zong)合性的(de)現(xian)代化(hua)GMP制(zhi)(zhi)(zhi)藥(yao)(yao)有(you)(you)限公(gong)(gong)(gong)司(si)。目前擁(yong)有(you)(you)7個(ge)子公(gong)(gong)(gong)司(si),是一家集中(zhong)藥(yao)(yao)制(zhi)(zhi)(zhi)劑(ji)、中(zhong)藥(yao)(yao)飲(yin)片、西(xi)藥(yao)(yao)制(zhi)(zhi)(zhi)劑(ji)、醫(yi)藥(yao)(yao)中(zhong)間體、化(hua)學原料藥(yao)(yao)、生物制(zhi)(zhi)(zhi)藥(yao)(yao)、保健品(pin)等(deng)生產(chan)、銷售和研(yan)發的(de)綜(zong)合型(xing)制(zhi)(zhi)(zhi)藥(yao)(yao)企業集團。公(gong)(gong)(gong)司(si)有(you)(you)中(zhong)西(xi)藥(yao)(yao)品(pin)種(zhong)200余種(zhong),中(zhong)藥(yao)(yao)產(chan)品(pin)主要(yao)有(you)(you)享譽海內外的(de)經典名藥(yao)(yao)“五朵金花”王(wang)氏(shi)保赤(chi)丸、季德(de)勝(sheng)蛇藥(yao)(yao)片、正柴胡飲(yin)顆粒(li)、大柴胡顆粒(li)、金蕎麥(mai)膠囊,以及固本(ben)咳喘片、暈可平糖漿、精血(xue)補(bu)片等(deng),這些中(zhong)藥(yao)(yao)品(pin)種(zhong)都有(you)(you)著廣(guang)泛(fan)的(de)歷史背景及深(shen)厚的(de)文化(hua)底蘊,其(qi)中(zhong)季德(de)勝(sheng)蛇藥(yao)(yao)片、王(wang)氏(shi)保赤(chi)丸制(zhi)(zhi)(zhi)作技藝均被列入國(guo)家非(fei)物質文化(hua)遺產(chan)。原料藥(yao)(yao)產(chan)品(pin)主要(yao)有(you)(you)苯巴比妥、撲(pu)米酮、氟尿嘧(mi)啶、保泰松、氟胞嘧(mi)啶、吡(bi)羅昔康、替諾昔康、丙硫氧嘧(mi)啶、非(fei)那西(xi)丁、雙(shuang)嘧(mi)達莫以及其(qi)它醫(yi)藥(yao)(yao)中(zhong)間體等(deng)。其(qi)中(zhong)已有(you)(you)10個(ge)品(pin)種(zhong)通(tong)過(guo)(guo)(guo)國(guo)家GMP認證,5個(ge)品(pin)種(zhong)通(tong)過(guo)(guo)(guo)歐盟(meng)CEP認證,2個(ge)品(pin)種(zhong)通(tong)過(guo)(guo)(guo)澳(ao)大利(li)亞(ya)GMP認證,3個(ge)品(pin)種(zhong)通(tong)過(guo)(guo)(guo)墨西(xi)哥(ge)官(guan)方(fang)認證,4個(ge)品(pin)種(zhong)獲得(de)美(mei)國(guo)DMF注(zhu)冊文件(jian)(jian) ,1個(ge)品(pin)種(zhong)獲得(de)美(mei)國(guo)VMF注(zhu)冊文件(jian)(jian),并已通(tong)過(guo)(guo)(guo)美(mei)國(guo)FDA現(xian)場核查。
精華(hua)制藥(yao)(yao)(yao)將會以“成為(wei)以傳世(shi)中(zhong)藥(yao)(yao)(yao)為(wei)核心(xin)特色的(de)(de)全國現代(dai)(dai)醫(yi)藥(yao)(yao)(yao)企業(ye)”為(wei)戰略(lve)目標,深入貫徹《關(guan)于促進(jin)中(zhong)醫(yi)藥(yao)(yao)(yao)傳承創(chuang)新發展的(de)(de)意見(jian)》精神,聚(ju)焦“五(wu)朵(duo)金花”傳世(shi)中(zhong)藥(yao)(yao)(yao)主業(ye)為(wei)主,特色化學原料(liao)藥(yao)(yao)(yao)及化學制劑為(wei)輔的(de)(de)“雙輪驅動(dong)”的(de)(de)發展戰略(lve),依(yi)托品牌力(li)和(he)渠道力(li),致力(li)于成為(wei)以傳世(shi)中(zhong)藥(yao)(yao)(yao)為(wei)核心(xin)特色的(de)(de)全國現代(dai)(dai)醫(yi)藥(yao)(yao)(yao)企業(ye)。